Indian Stock Market News, Equity Market and Sensex Today in India | Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Will Indian pharma buckle under regulations?
Tue, 21 Apr Pre-Open

Indian pharma companies have been facing the heat from a stringent US Food and Drug Administration (USFDA). As a majority of domestic generic companies derive a lion's share of revenues from the US market, the largest number of FDA-approved plants outside the US belongs to them.

In recent times, several domestic pharma companies have been pulled up for data integrity issues that include deficiency in manufacturing practices and drug tests. This has led to import alerts against companies such Sun Pharma, Wockhardt, Cadila Pharma, Orchid Pharma and Ipca Labs. In extreme cases, companies such as Ranbaxy were penalized with import bans imposed on some of its plants.

Apart from this, higher vigilance by USFDA has led to increase in waiting period for new drug approvals from 30 months to 42 months. This has pulled down the number of approvals from 100 in FY14 to 57 in FY15. Resultantly, domestic drug companies are expected to witness pressure on earnings in the short run.

However, the long term demand potential for generic drug companies remains bright. Indian drug companies have been strengthening quality and control processes to comply with USFDA's strict rules. As a result, the number of import alerts has come down from 21 in 2013 to 8 in 2014 (Source: India Ratings and Research).

According to The World Generic Medicines Congress Europe 2015, the patent on drugs valued at US$ 170 bn are set to expire in 2015 spurring demand for generics with the US market alone accounting for a huge share of 86-87%. It remains to be seen how well Indian drug companies will gear up to tap this huge off-patent drugs opportunity.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

Read the latest Market Commentary


What else is happening in the markets today? Dig in...

Equitymaster requests your view! Post a comment on "Will Indian pharma buckle under regulations?". Click here!

  

Views on News

Mirae Asset Tax Saver Fund: Seizing Superior Growth Opportunities (Outside View)

Apr 9, 2021

PersonalFN's analysis on the features and performance of Mirae Asset Tax Saver Fund.

Time to Change Our Trading Blueprint? (Fast Profits Daily)

Apr 9, 2021

The Indian government recently announced cut backs on crude oil imports from Saudi Arabia. Does this change our crude oil trading blueprint. Find out...

An India Revival Stock I'm Bullish On... (Profit Hunter)

Apr 9, 2021

This could take India to the position of 3rd largest economy.

Key Reasons Why Mutual Funds Turned Net Buyers in March 2021 (Outside View)

Apr 8, 2021

Domestic mutual funds have turned net buyers worth Rs 2,476 crore in the Indian equity markets in March 2021 for the first time in the last 10 months.

The Indians Are Coming (Fast Profits Daily)

Apr 8, 2021

In this video, I'll tell you why the Indian consumer has started to take the price of gold and silver higher.

More Views on News

Most Popular

A Critical Update on the Market (Fast Profits Daily)

Mar 30, 2021

In this video, I'll tell you why I am recommending caution in the market at this time.

My Recent Recommendation Will Profit from the Global Supply Chain Crisis (Profit Hunter)

Mar 31, 2021

A tiny chemical company, started in the Licence Raj era, is a great example of a new wealth creating opportunity.

My Stock Trading Strategy (Fast Profits Daily)

Mar 31, 2021

In this video I'll show you exactly how I go about picking stocks for trading.

What You Need to Find Hundred Baggers (Profit Hunter)

Mar 30, 2021

100 baggers of the last decade share this common trait. Here's how to use it to nail future multibaggers.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

S&P BSE SENSEX


Apr 9, 2021 (Close)

MARKET STATS